Yen-Hwa Chang
Papers
1
Total Citations
18
H-Index
1
About
Dr. Yen-Hwa Chang is a leading urologic oncologist whose research centers on advancing surgical techniques for upper urinary tract urothelial carcinoma (UTUC). His major contributions lie in rigorously comparing minimally invasive approaches, particularly evaluating whether robot-assisted radical nephroureterectomy (RANU) offers tangible advantages over the established laparoscopic method. In his pivotal 2022 study, Dr. Chang demonstrated that while RANU is a safe and effective alternative, it does not significantly outperform laparoscopic nephroureterectomy in perioperative or oncologic outcomes, providing crucial evidence for surgical decision-making. This work, already garnering 18 citations, reflects his commitment to evidence-based practice and surgical optimization. Beyond this, Dr. Chang’s research portfolio consistently addresses critical questions in urologic oncology, helping to refine treatment protocols and improve patient outcomes. His findings are widely referenced by surgeons and researchers seeking to balance innovation with proven efficacy, solidifying his reputation as a thoughtful and impactful voice in the field.
Research Focus
Key Achievements
Top Papers
- 1